Evidence map›Paper›PMID 23590591›Full record

ArticleACS nano2013

pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.

John T Wilson, Salka Keller, Matthew J Manganiello, Connie Cheng, Chen-Chang Lee, Chinonso Opara, Anthony Convertine, Patrick S Stayton

Abstract read
In one paragraph

Article in ACS nano, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 313 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

John T WilsonDepartment of Bioengineering, University of Washington, Seattle, Washington 98195, United States.
Salka Keller
Matthew J Manganiello
Connie Cheng
Chen-Chang Lee
Chinonso Opara
Anthony Convertine
Patrick S Stayton
University of Washington · US

Funding

Biofunctional Polymers for Intracellular Drug DeliveryR01EB002991 · NIBIB · UNIVERSITY OF WASHINGTON · PI STAYTON, PATRICK S. · 2003 to 2011
$3.9M
Biomaterials that Promote Infection ImmunityR01AI074661 · NIAID · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2008 to 2012
$2.5M
Biomaterials that Promote Infection ImmunityR56AI074661 · NIAID · UNIVERSITY OF WASHINGTON · PI BRYERS, JAMES D. · 2015 to 2015
$400k
NIAID NIH HHS R01 AI074661NIAID NIH HHS R01AI074661NIAID NIH HHS R56 AI074661NIBIB NIH HHS R01 EB002991NIBIB NIH HHS R01EB002991
6 · The paper itself

Abstract

Protein subunit vaccines offer important potential advantages over live vaccine vectors but generally elicit weaker and shorter-lived cellular immune responses. Here we investigate the use of pH-responsive, endosomolytic polymer nanoparticles that were originally developed for RNA delivery as vaccine delivery vehicles for enhancing cellular and humoral immune responses. Micellar nanoparticles were assembled from amphiphilic diblock copolymers composed of an ampholytic core-forming block and a redesigned polycationic corona block doped with thiol-reactive pyridyl disulfide groups to enable dual-delivery of antigens and immunostimulatory CpG oligodeoxynucleotide (CpG ODN) adjuvants. Polymers assembled into 23 nm particles with simultaneous packaging of CpG ODN and a thiolated protein antigen, ovalbumin (ova). Conjugation of ova to nanoparticles significantly enhanced antigen cross-presentation in vitro relative to free ova or an unconjugated, physical mixture of the parent compounds. Subcutaneous vaccination of mice with ova-nanoparticle conjugates elicited a significantly higher CD8(+) T cell response (0.5% IFN-γ(+) of CD8(+)) compared to mice vaccinated with free ova or a physical mixture of the two components. Significantly, immunization with ova-nanoparticle conjugates electrostatically complexed with CpG ODN (dual-delivery) enhanced CD8(+) T cell responses (3.4% IFN-γ(+) of CD8(+)) 7-, 18-, and 8-fold relative to immunization with conjugates, ova administered with free CpG, or a formulation containing free ova and CpG complexed to micelles, respectively. Similarly, dual-delivery carriers significantly increased CD4(+)IFN-γ(+) (Th1) responses and elicited a balanced IgG1/IgG2c antibody response. Intradermal administration further augmented cellular immune responses, with dual-delivery carriers inducing ∼7% antigen-specific CD8(+) T cells. This work demonstrates the ability of pH-responsive, endosomolytic nanoparticles to actively promote antigen cross-presentation and augment cellular and humoral immune responses via dual-delivery of protein antigens and CpG ODN. Hence, pH-responsive polymeric nanoparticles offer promise as a delivery platform for protein subunit vaccines.

Indexed as

NanoparticlesAdjuvants, ImmunologicAnimalsAntibodiesAntigen PresentationAntigensBiological TransportCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCpG IslandsCytosolDrug CarriersEndosomesFemaleHLA AntigensHydrogen-Ion ConcentrationAdjuvants, ImmunologicAntibodiesAntigensDrug CarriersHLA AntigensOligonucleotidesVaccines

Identifiers

PMID23590591
PMCPMC4042837
OpenAlexW1972141585

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.